ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Monte Rosa Therapeutics, Inc
A Contract Research Associate at Monte Rosa Therapeutics contributes to drug discovery through targeted protein degradation. The role involves cell and molecular biology research using CRISPR technology and lab automation tools.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Scientist II, Cell Line Engineering and CRISPR Screening
The Column Group (TCG)
Scientist I, Cell and Molecular Biology, Gene Editing
Editas Medicine
Research Associate, Cell & Gene Therapy
Insmed Incorporated
Laboratory Sciences Professional (Open Rank)
University of Colorado
Senior Scientist, Process Development-Cell Based Assay
Bpsbioscience
Vertex Exploratory Biology Co-Op
Vertex